Top 10 AI Tools for Veterinarians

Purpose-built AI clinical assistant that generates structured medical notes directly from doctor-patient conversations, solving a core veterinary workflow pain point that generalist tools cannot address with the same clinical accuracy and compliance focus.

Nabla earns a high operational score on the strength of 85,000+ active clinicians, 15+ EHR integrations including Epic Toolbox and athenahealth Marketplace, a free tier plus flat-rate paid plans ($119/mo), and consistent independent praise for accuracy and ease-of-use—with only minor caveats around occasional peak-traffic latency and MSE/A&P sections needing editing.

Nabla achieves near-top trust scores with SOC 2 Type 2, ISO 27001, HIPAA, GDPR, and NIST certifications all confirmed, an explicit no-audio-storage and no-model-training-on-patient-data policy, a clean public status page, and a $70M Series C in June 2025 signaling strong operational continuity.

Nabla's market position is very strong: $120M total funding (Series C led by HV Capital closed June 2025), named enterprise customers including CVS Health and Children's Hospital LA, Epic Toolbox and athenahealth Marketplace listings, and tier-1 press coverage from STAT News, FierceHealthcare, and Becker's Hospital Review—though G2/Capterra review counts remain modest (~13–15 reviews).

Nabla has a regionally versioned, documented API (us.api.nabla.com / eu.api.nabla.com) with auth guides, an async note generation endpoint, WebSocket streaming, and a changelog, but scores are dragged down by the absence of publicly documented rate limits, a limited mobile SDK footprint (iOS only confirmed), and no mention of LangChain/MCP orchestration support.

AI voice assistant specifically designed for healthcare practitioners to generate clinical notes from patient conversations, with veterinary-compatible clinical workflows, though primary positioning is human medicine rather than veterinary-specific features.

Suki delivers confirmed clinical-note automation with 72–76% documented time savings, deep bidirectional EHR integration with all four major platforms (Epic, Oracle, athenahealth, MEDITECH), and a KLAS 93.2/100 score — but its $299–$399/user/month enterprise-only pricing with no free tier drags down ROI accessibility significantly.

SOC 2 Type II certified, HIPAA compliant with BAA provided, PHI deidentified before LLM processing, and privacy policy updated May 2025 all support strong trust; a Series D-backed company with $165M raised and active executive hiring adds stability, though no public status page with historical uptime data was found.

Suki leads the ambient AI clinical documentation category with KLAS Best-in-Class 2025 honors, 400+ health system deployments, a $70M Series D at ~$400M valuation in October 2024, and named-enterprise partnership announcements (MedStar, Rush, McLeod Health) driving exceptionally strong market signals.

The developer.suki.ai portal offers a semantically versioned API with auth documentation, iOS/Android SDKs, and a partner SDK enabling ambient documentation embedding — but orchestration readiness is limited to healthcare-native contexts without general AI framework support (LangChain/LlamaIndex), and no public SLA percentage or historical status-page uptime data was found.

AI-powered search engine with cited sources excels at retrieving current veterinary research, clinical guidelines, and drug information during patient consultations, though it lacks veterinary-specific medical knowledge bases compared to purpose-built veterinary tools.

303 G2 reviews averaging 4.7/5, ease of setup scored 97% and ease of use 95%, with Zapier/Make/Gmail/Slack/Google Drive integrations confirmed and a meaningful free tier — operationally strong across all sub-dimensions with only minor hallucination rates (3.3% benchmark) tempering output reliability.

SOC 2 Type II confirmed alongside GDPR and PCI DSS, zero data retention policy for Sonar API users explicitly documented, and no training on enterprise data; penalized slightly by 25+ minor outages tracked on status page over ~1 year and consumer-tier training data ambiguity.

Raised $200M at $20B valuation in September 2025 with investors including NVIDIA, SoftBank, and Jeff Bezos; ARR grew to ~$200M by February 2026 with 100M+ MAU and 20,000+ enterprise organizations; tier-1 press coverage from TechCrunch and VentureBeat throughout the period.

Official Python (perplexity-py) and Node (perplexity-node) SDKs on GitHub with active commits as recently as January 2026 and changelog updated May 2026; LangChain and LlamaIndex integrations confirmed via AI SDK providers; Sonar API is versioned with full auth docs, though full OpenAPI spec availability and SLA documentation have minor gaps.

Superior medical translation accuracy enables veterinarians to serve multilingual clients and access international veterinary literature, but lacks healthcare-specific terminology optimization and medical context awareness compared to medical translation systems.

DeepL scores strongly on core utility (4.6/5 on G2 across 168 reviews, 89% accuracy benchmark, preferred 1.3x over Google Translate in blind tests) with deep integrations via Zapier, Make.com, and its own Marketplace launched September 2025, but reliability is modestly docked due to documented desktop app crashes, occasional service outages, and some user reports of quality regression in longer documents.

DeepL holds an exceptional trust posture with SOC 2 Type II, ISO 27001, HIPAA, C5 Type 2, and GDPR certifications, an explicit policy that texts are never stored or used for model training without consent, BYOK encryption support, and a publicly accessible status page — the highest-scoring dimension overall.

DeepL's $300M Series B at a $2B valuation (May 2024) and reported IPO targeting a $5B valuation in 2026, combined with $285M in 2025 revenue and the launch of DeepL Agent, DeepL Voice, and DeepL Marketplace, signal strong growth momentum, though G2 review volume (168) remains modest relative to category leaders.

DeepL offers a mature, versioned public API with a downloadable OpenAPI spec on GitHub, official SDKs for Python, Node.js, Java, .NET, Ruby, and PHP, active changelogs updated through Q4 2025, a Voice API with streaming support, and Make/Zapier orchestration — a near-complete developer surface with minor durability uncertainty due to an ongoing AWS infrastructure migration.

Meeting summaries and recordings support telemedicine consultations and staff training, but the tool is healthcare-agnostic without veterinary-specific features like encrypted storage or HIPAA compliance documentation that veterinary practices require.

Zoom AI Companion's core meeting-summary and workflow-integration capabilities are well-confirmed across 70K+ G2 reviews and deep native integrations with Salesforce, Slack, ServiceNow, and Microsoft/Google ecosystems, but documented summary-quality degradation (April 2025), misassigned action items, and occasional data-loss complaints pull output reliability into the 40–64 band, capping the operational score at 76.

Zoom holds SOC 2 Type II (Oct 2024–Oct 2025) plus ISO 27001 and HIPAA certifications and publicly reversed its AI-training-without-consent policy, but lingering reviewer complaints of AI-generated fictional action items and a 20–30% accuracy-issue rate across independent sources limit the trust score to 78.

With ~55.9% global video-conferencing market share, $4.67B FY2026 revenue, 192,600 enterprise customers, 71,979 G2 reviews, and strong tier-1 press coverage of AI Companion 3.0 (December 2025), Zoom commands one of the strongest market positions of any AI collaboration tool, scoring 88.

Zoom's developer platform features a versioned REST API with full webhook and MCP-server documentation, active changelogs updated through December 2025, multi-platform Meeting SDKs, LangChain/MCP orchestration support, and a public uptime history page, yielding a strong infrastructure score of 86.

AI customer support agent can handle pet owner FAQs (vaccinations, aftercare, appointment booking) reducing administrative burden, but it lacks veterinary-specific knowledge and cannot handle clinical triage or medical decision support.

Fin earns 4.5/5 across 3,851 G2 reviews with consistent praise for ticket deflection and ease of setup, but the $0.99/resolution pricing with no meaningful free tier and $29–$139/seat Intercom helpdesk add-on suppresses ROI accessibility, and occasional reports of struggles with complex or ambiguous queries temper output reliability.

Intercom holds SOC 2 Type II, ISO 27001, ISO 27701, ISO 27018, HIPAA, and GDPR certifications with a dedicated compliance team, a public status page tracking 48 components, and a documented 99.8% uptime SLA — among the strongest trust postures in the AI customer support category.

Fin crossed $100M ARR growing at 3.5x YoY, the parent company hit $400M ARR by April 2026, secured $250M in debt financing in March 2026, and the May 2026 corporate rebrand from Intercom to Fin signals AI-agent-first commitment backed by tier-1 press coverage including VentureBeat and The Irish Times.

The Intercom Developer Platform offers versioned REST APIs with full auth docs, webhooks with HMAC signing, SSE streaming, active GitHub SDKs for Node and Android with 2025 changelogs, and MCP support in early rollout — constituting a mature, orchestration-ready developer stack.

Improves clarity of clinical notes and client communications to reduce misunderstandings about treatment plans, but provides no veterinary terminology support or clinical documentation standards awareness that healthcare-specific writing tools offer.

Grammarly earns top marks for core utility — ranked #1 on G2's Winter 2026 Grid for AI Writing Assistants with 11,000+ reviews averaging 4.7/5 — with seamless integration across Gmail, Google Docs, MS Word, Slack, and browsers, a meaningful free tier, and near-zero learning curve; output reliability is solid but slightly discounted by recurring complaints about imprecise AI suggestions and an inaccurate plagiarism/AI detector.

Exceptional security posture with SOC 2 Type II, ISO 27001/27017/27018, HIPAA, and ISO 42001 certifications, explicit user opt-out from AI training in account settings, full GDPR compliance, and a live status page; output accuracy score is modestly reduced by documented complaints about AI suggestion quality and plagiarism detection inaccuracy.

Dominant market position with $1.5B+ total funding (General Catalyst major investor, 2025), strategic acquisitions of Coda and Superhuman Mail, 40M+ daily users across 50,000+ organizations, active tier-1 press coverage (TechCrunch, Fast Company, Inc.), and partner agents from Box and Gamma — reflecting a platform-scale ambition well beyond writing assistance.

REST API is versioned and documented at developer.grammarly.com with analytics (v2) and admin endpoints; Superhuman Agents SDK with MCP client support launched in closed beta (Feb 2026) signals strong orchestration direction, but the SDK is not yet publicly available for multiple languages and rate-limit documentation is sparse, keeping the infrastructure score in the high-mid range.

Free meeting recording and CRM auto-fill accelerates client notes entry during consultations, but lacks veterinary-specific data fields (pet species, medical history templates, diagnostic codes) that would make it truly optimized for practice management.

Fathom dominates its category with 6,684 G2 reviews at 5.0/5, confirmed unlimited free recording, 6,000+ Zapier integrations, native HubSpot/Salesforce/Slack/Asana sync, a public API, 1,443+ G2 mentions praising transcription accuracy, and a Capterra ease-of-use score of 4.97 — the only friction being the free tier's 5 AI summary/month cap.

SOC 2 Type II plus HIPAA and GDPR compliance are confirmed, AI sub-processors (Anthropic, OpenAI, Google) contractually barred from training on customer data, and a Trust Center is published; the score is modestly trimmed by ambiguous opt-out UX details and only minor status-page transparency relative to the product's scale.

Named to G2's 2026 Best Global Software Top 100, HubSpot's Most Used App of 2025, and Business Insider's 2026 unicorn watchlist, with a $73M valuation backed by a $17M Series A (Sep 2024) and 6,684 G2 reviews reflecting strong adoption velocity across individual and enterprise segments.

A public API is live at developers.fathom.ai with weekly changelog updates through May 2026 and GitHub activity as recent as Sep 2025, but versioning details, SDK availability (Python/JS), and webhook/streaming documentation are thin, capping the infrastructure ceiling despite healthy development cadence.

Generalist AI can assist with client communication templates, continuing education research, and practice management questions, but lacks veterinary clinical knowledge, medical compliance awareness, and should never substitute for veterinary-specific decision support systems.

Strong core utility confirmed by 1,929 G2 reviews at 4.7/5 and 96% ease-of-use, with 60+ integrations, Agent Mode, and a clean GPT-5 model lineup — penalised modestly for output reliability complaints on Trustpilot and accuracy issues on niche queries.

Privacy posture is ambiguous on AI training opt-outs, Trustpilot billing complaints signal operational trust failures, and no explicit SOC 2 Type II confirmation in evidence — partially offset by OpenAI's scale implying enterprise security infrastructure and a readable privacy policy.

700–900M weekly users, 2.5B daily prompts, 1,929 G2 reviews, $100 Pro tier directly competing with Anthropic, and consistent tier-1 press coverage make this the dominant market signal in the AI assistant category.

MCP SDK support, Python and Node SDKs, versioned API with documented token pricing, and active model releases every quarter score well — minor gaps in publicly confirmed rate limits and OpenAPI spec details in the evidence prevent a higher score.